World News: 21:44 GMT Thursday 8th November 2018. [Intrommune Therapeutics via Globe Newswire via SPi World News]
New York Nov 08 2018 GLOBE NEWSWIRE -- Intrommune Therapeutics a New York-based biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, is pleased to announce the first close of its Series A prefe...
Globe Newswire: 21:44 GMT Thursday 8th November 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.